Skip to Main Content

The (POGO) Blog

June 7, 2018

By Rebecca Jones

Patient Advocates Get Big Funding from Big Pharma



Two people meet Senator Claire McCaskill (D-MO) introduced legislation compelling patient advocacy groups to report funding they receive from pharmaceutical companies. This added transparency will give the public a new lens through which to view actions of these groups.

Continue Reading Patient Advocates Get Big Funding from Big Pharma

Topics: Public Health and Science

January 30, 2018

By Andrew Bergman

Scott Pruitt to Testify Today: Here Are POGO’s Most Pressing Questions



Scott Pruitt EPA Administrator Scott Pruitt will testify today in front of the Senate Committee on Environment and Public Works. POGO hopes for thorough answers about EPA accountability.

Continue Reading Scott Pruitt to Testify Today: Here Are POGO’s Most Pressing Questions

Topics: Government Accountability, Public Health and Science, Contract Oversight

November 22, 2017

By Daniel Van Schooten

Food Fight: Fighting for Food Safety Without a Champion



Thanksgiving dinner As you get ready to feast on turkey this Thanksgiving, one thing you can be thankful for is the U.S. Department of Agriculture’s (USDA) Food Safety and Inspection Service (FSIS).

Continue Reading Food Fight: Fighting for Food Safety Without a Champion

Topics: Government Accountability, Public Health and Science

August 12, 2016

By David S. Hilzenrath

UPDATE: DOJ Subpoenas Maker of Faulty Blood Testing Devices Spotlighted by POGO



Picture of a drop of blood on thumb. Alere Inc., maker of faulty INRatio blood testing devices, said it has received a Justice Department subpoena for records related to the devices’ accuracy and “interactions with the FDA.”

Continue Reading UPDATE: DOJ Subpoenas Maker of Faulty Blood Testing Devices Spotlighted by POGO

Topics: Government Accountability, Public Health and Science

July 13, 2016

By David S. Hilzenrath

FDA Says Faulty Devices Had "Minimal" Impact on Trial Led by New Boss



Picture of a drop of blood on thumb. The FDA said faulty INRatio blood testing devices had “minimal” impact on a clinical trial of blood thinner Xarelto that FDA head Robert Califf co-chaired.

Continue Reading FDA Says Faulty Devices Had "Minimal" Impact on Trial Led by New Boss

Topics: Government Accountability, Public Health and Science

Items 1 - 5 of 11  123Next

Browse POGOBlog by Topic

POGO on Facebook